|Publication number||USD214112 S|
|Publication date||May 6, 1969|
|Filing date||Apr 25, 1968|
|Publication number||US D214112 S, US D214112S, US-S-D214112, USD214112 S, USD214112S|
|Inventors||Arthur J. Langdon|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 0 "I e 214,112
Patented May 6, 1969 INTRAVENOUS NEEDLE HUB Arthur J. Langdon, East Hampton, Conn., assignor to Edward Weck & Company, Inc., Long Island City, N.Y., a corporation of Delaware Continuation-impart of design application Ser. No. 1,623, Mar. 24, 1966. This application Apr. 25, 1968, Ser. No. 11,614
Term of patent 14 years Int. Cl. D24-03 US. Cl. D83-12 FIG. 1 is a perspective view of an intravenous needle I claim: hub showing my new design; the broken lines illustrat- The ornamental design for an intravenous needle hub, ing the second hub indicate the intenfitting relationship substantially as shown and described. of the intravenous needle assembly;
FIG. 2 is a perspective view of the intravenous needle References Cited hub; the opposite side is a mirror image of the side that UNITED STATES PATENTS is shown' D. 95,090 4/1935 Son D83--12 12% 321s a side elevatlonal view of the needle hub D. 138,589 8/1944 Brandenburg 1,527,845 2/1925 Daniel.
FIG. 4 1s a plan view as seen from the rlgh slde of 3,175,554 3/1965 Stewart 128 2 FIG. 2; and
FIG. 5 is a plan view as seen from the left side of FOREIGN PATENTS FIG. 2.
The broken lines are shown for illustrative purposes 1,175,389 11/ 1958 France. only.
This is a continuation-in-part of Design application BERNARD ANSHER Primary Examiner- Ser. No. D. 1,623, filed Mar. 24, 1966 and now a=bondoned.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8603028||Mar 16, 2012||Dec 10, 2013||Allergan, Inc.||Injection device having an angled tip portion|
|US8801659||Jun 1, 2009||Aug 12, 2014||Allergan, Inc.||Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form|
|US8888751||Jul 29, 2013||Nov 18, 2014||Allergan, Inc.||Slotted syringe|
|US8992481||Jun 11, 2013||Mar 31, 2015||Allergan, Inc.||Modular injection device|
|US9095654||Aug 14, 2013||Aug 4, 2015||Allergan, Inc.||Syringe for mixing and dispensing adipose tissue|
|US9468720||Nov 12, 2013||Oct 18, 2016||Allergan, Inc.||Injection device having an angled tip portion|
|US20110092916 *||Oct 25, 2010||Apr 21, 2011||Allergan, Inc.||Injection device|
|US20110137286 *||Jun 1, 2009||Jun 9, 2011||Allergan, Inc.||Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form|